<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00746564</url>
  </required_header>
  <id_info>
    <org_study_id>60020941D</org_study_id>
    <nct_id>NCT00746564</nct_id>
  </id_info>
  <brief_title>Study of New Implantable Loop Recorder</brief_title>
  <official_title>Confirm Implantable Cardiac Monitor Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Jude Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this IDE clinical study is to evaluate the quality of the cardiac signal
      recordings obtained by the St. Jude Medical (SJM) Confirm Implantable Cardiac Monitor
      (device).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity for R Waves During In-Clinic Recordings at Rest</measure>
    <time_frame>6 weeks</time_frame>
    <description>The sensitivity was calculated for each recording and for each subject.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensitivity for R Waves During In-Clinic Recordings During Treadmill Exercise</measure>
    <time_frame>6 weeks</time_frame>
    <description>The sensitivity for R waves during the in-clinic recordings was was calculated for each recording and for each subject.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Sensitivity for R Waves During In-Clinic Recordings During Hand to Hand/Shoulder Maneuvers</measure>
    <time_frame>6 weeks</time_frame>
    <description>The sensitivity for R waves during the in-clinic recordings was was calculated for each recording and for each subject.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Predictive Value (PPV) for In-Clinic Recordings at Rest</measure>
    <time_frame>6 weeks</time_frame>
    <description>The positive predictive value (PPV) for the in-clinic recording was calculated for each recording and for each subject.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Predictive Value (PPV) for In-Clinic Recordings During Treadmill Stress Test</measure>
    <time_frame>6 weeks</time_frame>
    <description>The positive predictive value (PPV) for the in-clinic recording was calculated for each recording and for each subject.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Positive Predictive Value (PPV) During Hand to Hand/Shoulder Maneuvers</measure>
    <time_frame>6 weeks</time_frame>
    <description>The positive predictive value (PPV) for the in-clinic recording was was calculated for each recording and for each subject.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Interpretability of Weekly Subject Activator Recordings</measure>
    <time_frame>6 weeks</time_frame>
    <description>The proportion of recording time during which the device recording was interpretable was calculated for each weekly Patient Activator recording and for each subject. A random effects model was fitted to the data.</description>
  </other_outcome>
  <other_outcome>
    <measure>Interpretability of Automatically Triggered/Symptom Driven Recordings</measure>
    <time_frame>6 weeks</time_frame>
    <description>The proportion of recording time during which the device recording was interpretable for each automatically triggered/symptom driven recording and for each subject.</description>
  </other_outcome>
  <other_outcome>
    <measure>Inappropriateness of Automatically Triggered Recordings - Phase I</measure>
    <time_frame>6 weeks</time_frame>
    <description>The proportion of automatically triggered recordings that were inappropriate (i.e. noise triggered)was calculated and reported using a generalized estimating equation (GEE) model for binomial outcomes to account for multiple recordings per patient.</description>
  </other_outcome>
  <other_outcome>
    <measure>Inappropriateness of Automatically Triggered Recordings - Phase II</measure>
    <time_frame>6 weeks</time_frame>
    <description>The proportion of automatically triggered recordings that were inappropriate (i.e. noise triggered)was calculated and reported using a GEE model for binomial outcomes to account for multiple recordings per patient.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Tachyarrhythmias</condition>
  <condition>Syncope</condition>
  <arm_group>
    <arm_group_label>Open Label</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>SJM Confirm Device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SJM Confirm</intervention_name>
    <description>All patients in this study will receive the SJM Confirm device.</description>
    <arm_group_label>Open Label</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have clinical syndromes or situations at increased risk of cardiac
             arrhythmias

          -  Patients who experience transient symptoms that may suggest a cardiac arrhythmia

          -  Patients who have been previously diagnosed with atrial fibrillation

          -  Patients who are suspected to have Atrial Fibrillation (AF) but AF has not been
             documented

          -  Patients who have provided written informed consent to participate in the study.

        Exclusion Criteria:

          -  Patients who are under the age of 18 years

          -  Patients who have a life expectancy less than 1 year

          -  Patients who are unable to comply with the follow-up schedule

          -  Patients who are currently implanted with a pacemaker or defibrillator

          -  Patients who the physician deems inappropriate for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tamara Shipman</last_name>
    <role>Study Director</role>
    <affiliation>St. Jude Medical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alaska Heart Institute</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Arrhythmia Research</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Heart Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Jude Hospital</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <zip>92835-2605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scripps Clinic</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Heart Institute at Utica</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence- St Vincent Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97225</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia Research Foundation</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22980</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2008</study_first_submitted>
  <study_first_submitted_qc>September 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 4, 2008</study_first_posted>
  <results_first_submitted>April 13, 2015</results_first_submitted>
  <results_first_submitted_qc>April 13, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 30, 2015</results_first_posted>
  <disposition_first_submitted>August 24, 2012</disposition_first_submitted>
  <disposition_first_submitted_qc>August 24, 2012</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">August 31, 2012</disposition_first_posted>
  <last_update_submitted>November 1, 2015</last_update_submitted>
  <last_update_submitted_qc>November 1, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Implantable Cardiac Monitor</keyword>
  <keyword>Arrhythmias</keyword>
  <keyword>Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syncope</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>SJM Confirm Device</title>
          <description>All patients in this study received the St. Jude Medical (SJM Confirm device.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Required Pacemaker/ICD Implant</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All patients implanted with the Confirm Device.</population>
      <group_list>
        <group group_id="B1">
          <title>Open Label</title>
          <description>All patients who were implanted with the SJM Confirm device.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62" lower_limit="19" upper_limit="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Sensitivity for R Waves During In-Clinic Recordings at Rest</title>
        <description>The sensitivity was calculated for each recording and for each subject.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I were included in this analysis. Total patients 48; 50-(1 withdrawal)-(1 patient with recording lacking the surface channel). Total analyzable recordings 88; 89-(1 recording lacking visible R waves).</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients in this study received the SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity for R Waves During In-Clinic Recordings at Rest</title>
          <description>The sensitivity was calculated for each recording and for each subject.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I were included in this analysis. Total patients 48; 50-(1 withdrawal)-(1 patient with recording lacking the surface channel). Total analyzable recordings 88; 89-(1 recording lacking visible R waves).</population>
          <units>percentage of recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Clinical recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="88"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="100" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The sensitivity was calculated for each recording and for each subject as follows:
Amount of time (sec) R waves recorded on surface ECG were detected on in-clinic recordings/Total amount of time (sec) R waves were recorded on surface ECG</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of recordings</param_type>
            <param_value>100</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>100</ci_lower_limit>
            <ci_upper_limit>100</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sensitivity for R Waves During In-Clinic Recordings During Treadmill Exercise</title>
        <description>The sensitivity for R waves during the in-clinic recordings was was calculated for each recording and for each subject.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 46; 50-(1 withdrawal)-(1 patient's recording lacking surface ECG channel)-(2 no recording obtained). Total analyzable recordings =39; 46 obtained-(7 with zero visible R waves).</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients in this study received the SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity for R Waves During In-Clinic Recordings During Treadmill Exercise</title>
          <description>The sensitivity for R waves during the in-clinic recordings was was calculated for each recording and for each subject.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 46; 50-(1 withdrawal)-(1 patient's recording lacking surface ECG channel)-(2 no recording obtained). Total analyzable recordings =39; 46 obtained-(7 with zero visible R waves).</population>
          <units>percentage of recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="46"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Clinical Recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.1" lower_limit="95.7" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The sensitivity was calculated for each recording during the treadmill test and for each subject as follows:
Amount of time (sec) R waves recorded on surface ECG were detected on in-clinic recordings/Total amount of time (sec) R waves were recorded on surface ECG</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of clinical recordings</param_type>
            <param_value>98.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>95.7</ci_lower_limit>
            <ci_upper_limit>100</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Sensitivity for R Waves During In-Clinic Recordings During Hand to Hand/Shoulder Maneuvers</title>
        <description>The sensitivity for R waves during the in-clinic recordings was was calculated for each recording and for each subject.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 48; 50-(1 withdrawal)-(1 patient recording lacking surface ECG channel). Total analyzable recordings 82; 96 obtained-(14 recordings with zero visible R waves)=82 recordings</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients in this study received the SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Sensitivity for R Waves During In-Clinic Recordings During Hand to Hand/Shoulder Maneuvers</title>
          <description>The sensitivity for R waves during the in-clinic recordings was was calculated for each recording and for each subject.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 48; 50-(1 withdrawal)-(1 patient recording lacking surface ECG channel). Total analyzable recordings 82; 96 obtained-(14 recordings with zero visible R waves)=82 recordings</population>
          <units>percentage of recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Clinical Recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.0" lower_limit="95.5" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The sensitivity was calculated for each recording and for each subject during the hand to hand and hand to shoulder maneuvers as follows:
Amount of time (sec) R waves recorded on surface ECG were detected on in-clinic recordings/Total amount of time (sec) R waves were recorded on surface ECG</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of recordings</param_type>
            <param_value>98.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>95.5</ci_lower_limit>
            <ci_upper_limit>100</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Predictive Value (PPV) for In-Clinic Recordings at Rest</title>
        <description>The positive predictive value (PPV) for the in-clinic recording was calculated for each recording and for each subject.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 48; 50-(1 withdrawal)-(1 patient with no recording obtained). Total analyzable recordings 89.</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients in this study received the SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Predictive Value (PPV) for In-Clinic Recordings at Rest</title>
          <description>The positive predictive value (PPV) for the in-clinic recording was calculated for each recording and for each subject.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 48; 50-(1 withdrawal)-(1 patient with no recording obtained). Total analyzable recordings 89.</population>
          <units>percentage of recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Clinical Recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="89"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="98.9" lower_limit="96.7" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The positive predictive value (PPV) was calculated for each recording and for each subject during the in-clinic recording at rest as follows:
Amount of time (sec) R waves recorded on surface ECG were detected on in-clinic recording / Total amount of time (sec) R waves were recorded by device during in-clinic recording</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of recordings</param_type>
            <param_value>98.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>96.7</ci_lower_limit>
            <ci_upper_limit>100</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Predictive Value (PPV) for In-Clinic Recordings During Treadmill Stress Test</title>
        <description>The positive predictive value (PPV) for the in-clinic recording was calculated for each recording and for each subject.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 45; 50-(1 withdrawal)-(1 patient recording lacking surface ECG channel)-(2 patients where no recording was obtained). Total analyzable recordings 45: 46 obtained-(1 recording with zero visible R waves).</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients in this study received the SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Predictive Value (PPV) for In-Clinic Recordings During Treadmill Stress Test</title>
          <description>The positive predictive value (PPV) for the in-clinic recording was calculated for each recording and for each subject.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 45; 50-(1 withdrawal)-(1 patient recording lacking surface ECG channel)-(2 patients where no recording was obtained). Total analyzable recordings 45: 46 obtained-(1 recording with zero visible R waves).</population>
          <units>percentage of recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Clinical recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.1" lower_limit="65.9" upper_limit="88.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The positive predictive value (PPV) was calculated for each recording and for each subject for the in-clinic recording during the treadmill exercise as follows:
Amount of time (sec) R waves recorded on surface ECG were detected on in-clinic recording / Total amount of time (sec) R waves were recorded by device during in-clinic recording</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of recording</param_type>
            <param_value>77.1</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>65.9</ci_lower_limit>
            <ci_upper_limit>88.4</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Positive Predictive Value (PPV) During Hand to Hand/Shoulder Maneuvers</title>
        <description>The positive predictive value (PPV) for the in-clinic recording was was calculated for each recording and for each subject.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 48; 50-(1 withdrawal)-(1 patient recording lacking surface ECG channel). Total analyzable recordings 92: 96 obtained-(4 recordings with zero visible R waves)</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients in this study received the SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Positive Predictive Value (PPV) During Hand to Hand/Shoulder Maneuvers</title>
          <description>The positive predictive value (PPV) for the in-clinic recording was was calculated for each recording and for each subject.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 48; 50-(1 withdrawal)-(1 patient recording lacking surface ECG channel). Total analyzable recordings 92: 96 obtained-(4 recordings with zero visible R waves)</population>
          <units>percentage of recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Clinical Recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.0" lower_limit="78.3" upper_limit="91.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The positive predictive value (PPV) was calculated for each recording and for each subject during Hand to Hand and Hand to Shoulder Maneuvers as follows:
Amount of time (sec) R waves recorded on surface ECG were detected on in-clinic recording / Total amount of time (sec) R waves were recorded by device during in-clinic recording</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Percentage of recordings</param_type>
            <param_value>85.0</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>78.3</ci_lower_limit>
            <ci_upper_limit>91.7</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Interpretability of Weekly Subject Activator Recordings</title>
        <description>The proportion of recording time during which the device recording was interpretable was calculated for each weekly Patient Activator recording and for each subject. A random effects model was fitted to the data.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 30; 50-(1 withdrawal)-(19 patients who did not initiate recordings). Total analyzable recordings 58.</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients in this study received the SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Interpretability of Weekly Subject Activator Recordings</title>
          <description>The proportion of recording time during which the device recording was interpretable was calculated for each weekly Patient Activator recording and for each subject. A random effects model was fitted to the data.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 30; 50-(1 withdrawal)-(19 patients who did not initiate recordings). Total analyzable recordings 58.</population>
          <units>percentage of interpretable recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Clinical Recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.2" lower_limit="98.5" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The proportion of recording time during which the device recording was interpretable was calculated for each weekly Patient Activator recording and for each subject as follows:
Duration (sec) of interpretable recording / Total duration of recording time (sec)</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of interpretable recording</param_type>
            <param_value>99.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>98.5</ci_lower_limit>
            <ci_upper_limit>100</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Interpretability of Automatically Triggered/Symptom Driven Recordings</title>
        <description>The proportion of recording time during which the device recording was interpretable for each automatically triggered/symptom driven recording and for each subject.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 47; 50-(1 withdrawal)-(2 patients whose recordings were lost due to programming changes). Total analyzable recordings 2804.</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients implanted with an SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Interpretability of Automatically Triggered/Symptom Driven Recordings</title>
          <description>The proportion of recording time during which the device recording was interpretable for each automatically triggered/symptom driven recording and for each subject.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 47; 50-(1 withdrawal)-(2 patients whose recordings were lost due to programming changes). Total analyzable recordings 2804.</population>
          <units>percentage of interpretable recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2804"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" lower_limit="91.9" upper_limit="92.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The proportion of recording time during which the device recording was interpretable for each automatically triggered/symptom driven recording and for each subject was calculated as follows:
Duration of interpretable recording / Total duration of recording time</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of interpretable recording</param_type>
            <param_value>92.3</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>91.9</ci_lower_limit>
            <ci_upper_limit>92.6</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Inappropriateness of Automatically Triggered Recordings – Phase I</title>
        <description>The proportion of automatically triggered recordings that were inappropriate (i.e. noise triggered)was calculated and reported using a generalized estimating equation (GEE) model for binomial outcomes to account for multiple recordings per patient.</description>
        <time_frame>6 weeks</time_frame>
        <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 47; 50-(1 withdrawal)-(2 patients whose recordings were lost due to programming changes).</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients implanted with an SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Inappropriateness of Automatically Triggered Recordings – Phase I</title>
          <description>The proportion of automatically triggered recordings that were inappropriate (i.e. noise triggered)was calculated and reported using a generalized estimating equation (GEE) model for binomial outcomes to account for multiple recordings per patient.</description>
          <population>50 patients implanted with the SJM Confirm device in Phase I. Total patients 47; 50-(1 withdrawal)-(2 patients whose recordings were lost due to programming changes).</population>
          <units>percentage of inappropriate recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Recordings</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2741"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.2" lower_limit="79.4" upper_limit="91.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of inappropriate recordings</param_type>
            <param_value>86.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>79.4</ci_lower_limit>
            <ci_upper_limit>91.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Inappropriateness of Automatically Triggered Recordings – Phase II</title>
        <description>The proportion of automatically triggered recordings that were inappropriate (i.e. noise triggered)was calculated and reported using a GEE model for binomial outcomes to account for multiple recordings per patient.</description>
        <time_frame>6 weeks</time_frame>
        <population>All patients implanted with the SJM Confirm device in participating in Phase II. Total patients 36: (19 rollovers from Phase I enrollments)+(25 Phase II enrollments)-(1 withdrawal)-(7 subjects with no automatically triggered recordings). Total recordings obtained: 958</population>
        <group_list>
          <group group_id="O1">
            <title>SJM Confirm Device</title>
            <description>All patients implanted with the SJM Confirm device.</description>
          </group>
        </group_list>
        <measure>
          <title>Inappropriateness of Automatically Triggered Recordings – Phase II</title>
          <description>The proportion of automatically triggered recordings that were inappropriate (i.e. noise triggered)was calculated and reported using a GEE model for binomial outcomes to account for multiple recordings per patient.</description>
          <population>All patients implanted with the SJM Confirm device in participating in Phase II. Total patients 36: (19 rollovers from Phase I enrollments)+(25 Phase II enrollments)-(1 withdrawal)-(7 subjects with no automatically triggered recordings). Total recordings obtained: 958</population>
          <units>percentage of inappropriate recordings</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>Recording</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="958"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="62.3" lower_limit="48.1" upper_limit="76.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>percentage of inappropriate recordings</param_type>
            <param_value>63.2</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>48.1</ci_lower_limit>
            <ci_upper_limit>76.2</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Baseline, 6-Week, 3-Month, and every 6 Months for the duration of the study or up to 5 years.</time_frame>
      <desc>Patients were assessed for adverse events, and the Confirm device was evaluated at each study visit.</desc>
      <group_list>
        <group group_id="E1">
          <title>SJM Confirm Device</title>
          <description>All patients in this study received the SJM Confirm device.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>PREMATURE BATTERY DEPLETION/ ICM</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>DEVICE EXTRUSION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>VAGAL REACTION</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>EARLY BATTERY DEPLETION/ PATIENT ACTIVATOR</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Excessive Noise on the EGM Resulting in Inability to Interpret the EGM</sub_title>
                <counts group_id="E1" events="12" subjects_affected="7" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Undersensing</sub_title>
                <counts group_id="E1" events="14" subjects_affected="9" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director, Clinical Studies</name_or_title>
      <organization>St. Jude Medical</organization>
      <phone>1-800-733-3455</phone>
      <email>tshipman@sjm.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

